1. 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Issue 5 (15th April 2020) Authors: Du, Chenxing; Mao, Xuehan; Xu, Yan; Yan, Yuting; Yuan, Chenglu; Du, Xin; Liu, Jiahui; Fan, Huishou; Wang, Qi; Sui, Weiwei; Deng, Shuhui; Fu, Mingwei; Li, Zengjun; Li, Chengwen; Zhao, Jiawei; Yi, Shuhua; Liu, Lanting; Hao, Mu; Zou, Dehui; Zhao, Yaozhong Journal: Leukemia & lymphoma Issue: Volume 61:Issue 5(2020) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter, open‐label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma. Issue 11 (29th September 2014) Authors: Geng, Chuanying; Hou, Jian; Zhao, Yaozhong; Ke, Xiaoyan; Wang, Zhao; Qiu, Lugui; Xi, Hao; Wang, Fuxu; Wei, Na; Liu, Yan; Yang, Shifang; Wei, Peng; Zheng, Xiangjun; Huang, Zhongxia; Zhu, Bing; Chen, Wen‐Ming Journal: American journal of hematology Issue: Volume 89:Issue 11(2014:Nov.) Page Start: 1037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma. (October 2018) Authors: Hou, Jian; Qiu, Lugui; Zhao, Yaozhong; Zhang, Xuejun; Liu, Yan; Wang, Zhao; Zhou, Fang; Leng, Yun; Yang, Shifang; Xi, Hao; Wang, Fuxu; Zhu, Bing; Chen, Wenming; Wei, Peng; Zheng, Xiangjun Journal: American journal of clinical oncology Issue: Volume 41:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem/progenitor cells mobilization1. Issue 5 (28th January 2013) Authors: Li, Sidan; Zhai, Qiongli; Zou, Dehui; Meng, Hengxing; Xie, Zhenqing; Li, Changhong; Wang, Yafei; Qi, Junyuan; Cheng, Tao; Qiu, Lugui Journal: Journal of cellular physiology Issue: Volume 228:Issue 5(2013:May) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem/progenitor cells mobilization1. Issue 5 (28th January 2013) Authors: Li, Sidan; Zhai, Qiongli; Zou, Dehui; Meng, Hengxing; Xie, Zhenqing; Li, Changhong; Wang, Yafei; Qi, Junyuan; Cheng, Tao; Qiu, Lugui Journal: Journal of cellular physiology Issue: Volume 228:Issue 5(2013:May) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A two‐part, single‐arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B‐cell malignancies. (5th April 2022) Authors: Song, Yuqin; Sun, Mingyuan; Qi, Junyuan; Xu, Wei; Zhou, Jianfeng; Li, Dengju; Li, Jianyong; Qiu, Lugui; Du, Chenmu; Guo, Haiyi; Huang, Jane; Tang, Zhiyu; Ou, Ying; Wu, Binghao; Yu, Yiling; Zhu, Jun Journal: British journal of haematology Issue: Volume 198:Number 1(2022) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase. Issue 1 (December 2017) Authors: Zou, Dehui; Yi, Shuhua; Cui, Rui; Liu, Wei; Li, Chengwen; Zhong, Shizhen; Yu, Zhen; Li, Zengjun; Lv, Rui; Ru, Kun; Wang, Huijun; An, Gang; Xu, Yan; Qiu, Lugui Journal: BMC medical genetics Issue: Volume 18:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma. Issue 2 (9th December 2022) Authors: Li, Ru; Wang, Tingyu; Lyv, Rui; Wang, Yi; Yu, Ying; Yan, Yuting; Sun, Qi; Xiong, Wenjie; Liu, Wei; Sui, Weiwei; Huang, Wenyang; Wang, Huijun; Li, Chengwen; Wang, Jun; Zou, Dehui; An, Gang; Wang, Jianxiang; Qiu, Lugui; Yi, Shuhua Journal: Blood science Issue: Volume 5:Issue 2(2023) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Continuous treatment with lenalidomide and low‐dose dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial. (20th January 2017) Authors: Lu, Jin; Lee, Jae H.; Huang, Shang‐Yi; Qiu, Lugui; Lee, Je‐Jung; Liu, Ting; Yoon, Sung‐Soo; Kim, Kihyun; Shen, Zhi X.; Eom, Hyeon S.; Chen, Wen M.; Min, Chang K.; Kim, Hyo J.; Lee, Jeong O.; Kwak, Jae Y.; Yiu, Wai; Chen, Guang; Ervin‐Haynes, Annette; Hulin, Cyrille; Facon, Thierry Journal: British journal of haematology Issue: Volume 176:Number 5(2017) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Issue 7 (July 2015) Authors: Li, Fei; Hao, Mu; Feng, Xiaoyan; Zang, Meirong; Qin, Yu; Yi, Shuhua; Li, Zengjun; Xu, Yan; Zhou, Lili; Sui, Weiwei; Deng, Shuhui; Zou, Dehui; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗